The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Japan Medical Dynamic Marketing's share price is €4.92.
Japan Medical Dynamic Marketing's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €5.15. Hence, Japan Medical Dynamic Marketing's PS Ratio for today is 0.96.
Warning Sign:
Japan Medical Dynamic Marketing Inc stock PS Ratio (=0.99) is close to 2-year high of 1.01.
The historical rank and industry rank for Japan Medical Dynamic Marketing's PS Ratio or its related term are showing as below:
FRA:JMD'
s PS Ratio Range Over the Past 10 Years
Min: 0.5 Med: 1.73 Max: 3.86
Current: 1.05
During the past 13 years, Japan Medical Dynamic Marketing's highest PS Ratio was 3.86. The lowest was 0.50. And the median was 1.73.
FRA:JMD's PS Ratio is ranked better than 81.32% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.92
vs FRA:JMD: 1.05
During the past 13 years, Japan Medical Dynamic Marketing's highest 3-Year average Revenue per Share Growth Rate was 17.00% per year. The lowest was -16.50% per year. And the median was 7.50% per year.
Back to Basics: PS Ratio
Japan Medical Dynamic Marketing (FRA:JMD) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Japan Medical Dynamic Marketing PS Ratio Related Terms
Japan Medical Dynamic Marketing PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Japan Medical Dynamic Marketing's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Medical Dynamic Marketing PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Medical Dynamic Marketing's PS Ratio distribution charts can be found below:
* The bar in red indicates where Japan Medical Dynamic Marketing's PS Ratio falls into.
Japan Medical Dynamic Marketing PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Japan Medical Dynamic Marketing's Share Price of today is €4.92. Japan Medical Dynamic Marketing's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.15.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Japan Medical Dynamic Marketing (FRA:JMD) has a PS Ratio of 0.96 as of Jul. 11, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Japan Medical Dynamic Marketing and its competitors. This is 45% below median its historical median of 1.73. Over the past decade, Japan Medical Dynamic Marketing's PS Ratio has ranged from 0.50 to 3.86. According to the industry distribution chart, Japan Medical Dynamic Marketing ranks #150 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 18.7%.
Is Japan Medical Dynamic Marketing's PS Ratio too high?
Japan Medical Dynamic Marketing's current PS Ratio of 0.96 is 45% below median its 10-year median of 1.73. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 3.86. The Medical Devices & Instruments industry median PS Ratio is 2.92. Japan Medical Dynamic Marketing's value of 0.96 is 67.1% below this industry median. Based on the distribution chart, Japan Medical Dynamic Marketing ranks #150 out of 803 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Medical Dynamic Marketing ranks #150 out of 803 companies for PS Ratio. This places Japan Medical Dynamic Marketing in the top 19% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.92. Japan Medical Dynamic Marketing's value of 0.96 is 67.1% below this benchmark. Historically, Japan Medical Dynamic Marketing's own PS Ratio has ranged from 0.50 to 3.86 over the past decade. While the company's 10-year median is 1.73 vs. the industry median of 2.92, Japan Medical Dynamic Marketing has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.92, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Medical Dynamic Marketing's current PS Ratio of 0.96 is 67.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Japan Medical Dynamic Marketing and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Medical Dynamic Marketing's current PS Ratio is 0.96, which is 45% below median its own 10-year median of 1.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Japan Medical Dynamic Marketing (FRA:JMD) has a current PS Ratio of 0.96. The stock's GF Value™ is €3.39, compared to a current price of €4.92 — trading 45.1% above its estimated fair value. The current PS Ratio is 0.96, which is 45% below median its 10-year median of 1.73 and 67.1% below the Medical Devices & Instruments industry median of 2.92. Japan Medical Dynamic Marketing's overall GF Score™ is 77/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (FRA:JMD), the current PS Ratio is 0.96 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Medical Dynamic Marketing (FRA:JMD) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued.
The current stock price of €4.92 is trading 45.1% above its estimated GF Value™ of €3.39.
Key valuation signals for FRA:JMD:
PS Ratio: 0.96 (45% below median its 10-year median of 1.73)
GF Value™: €3.39 vs. price of €4.92 (45.1% above fair value)
Industry Position: 67.1% below the Medical Devices & Instruments median (#150 of 803)
No single metric tells the full story. See the FRA:JMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Medical Dynamic Marketing Business Description
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
77GF Score
Get the complete analysis for FRA:JMD
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:JMD has been successfully added to your 
